chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse (also reported as healthcare worker) referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients received an improperly stored dose of GARDASIL 9 (lot# M003659, expiration date 20-SEP-2017; lot# M011117, expiration date 07-DEC-2017; dose and route were unknown) for prophylaxis. No adverse effects were reported. The vaccines were stored under 49.1 Fahrenheit degrees for 40 minutes. On 30-NOV-2016, a call was placed to the registered nurse.  The healthcare provider was unable to answer the telephone call.  A detailed message was left requesting a return telephone call.  All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1610USA002044: MERCK 1610USA005665: Mfr number.
1450 patient reported dizziness, responding verbally with clear speech. Denied headache, stated he has not eaten since breakfast. No tongue edema noted. Normal respiratory BP 113/51 P72 T 97.3 O2 sat 96 pt denied dysphagia. Mother, father, sister present. Oatmeal bars X2, 4 oz orange juice, 8 oz water, 1 pk  cookies consumed. remained verbally responsive, followed commands 1500 BS 95 after shock and fluids 1510 stated feeling better bp 111/56 64 p, O2 sat 97%, 1525 stated feeling much better and comfortable enough to leave. Patient exited with parents to drive him home.
It was Monday morning, my symptoms were dizziness and nauseas for a couple of weeks. I looked it up and it was the same exact symptoms of Vertigo. I did not see a doctor because there is no medication for vertigo that I know of.  I had to shut my eyes because I was so dizzy, I had to run out of the bathroom and get my head straight. I think It's from the vaccine because I've never had it in my life. This lasted 4 days.
Left upper arm welt, Redness and swelling, soreness on movement, sore to the touch. Reported on 9/29/2011.
CHILLS; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced chills, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and chills was not reported. This report was non-serious.
Patient described a tingling tongue about 5 minutes after receiving vaccine. She was carefully observed, then stated the top of her mouth started tingling too. She was given 50mg of benadryl PO. Patient stayed onsite around 30 minutes, and was comfortable leaving with her husband. We followed up around 7pm, and she was feeling fine.
Narrative:  Patient received two doses of Pfizer COVID 19 vaccine in March 21. The patient tested positive for COVID 19 on 16 September and was hospitalized with sepsis and COVID 19 Pneumonia. The patient was treated and discharged on 22 Sep 21. The EUA requires that any patients that tested positive for COVID 19 and required hospitalization after receiving the vaccine must be reported.
aches and pain in her shoulder and neck; had exceptionally felt like she wanted to go to bed and nap; She was not able to sleep and did not get up until 10 today; painful and hard; She stated to move her hair even to the touch it is painful; definitely something abnormal; Her hands, mainly her right, and ankles are swollen; Her hands, mainly her right, and ankles are swollen; congested in her chest; she is feeling a little confused; horrendous lumps on her head (some the size of a quarter, some a half dollar; fever; Excruciating pain in my head; peculiar neck pain/ aches and pain in her shoulder and neck; swelling of my arms and hands; Felt Achy; Felt off balance; chills; This is a spontaneous report from a contactable consumer reporting for herself.  A 68-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  Medical history included thyroid mass (Diagnosed over 5 years ago. She never got a biopsy of it) , pelvic mass , cardiac disorder (Diagnosed when she was 49 or 50) , cardiac pacemaker insertion.   The patient's concomitant medications were not reported.  The patient experienced horrendous lumps on her head (some the size of a quarter, some a half dollar on an unspecified date with outcome of unknown , felt off balance  on 12Apr2021 with outcome of not recovered , peculiar neck pain/ aches and pain in her shoulder and neck  on 13Apr2021 with outcome of unknown , aches and pain in her shoulder and neck on an unspecified date with outcome of unknown , had exceptionally felt like she wanted to go to bed and nap  on an unspecified date with outcome of unknown , she was not able to sleep and did not get up until 10 today  on an unspecified date with outcome of unknown , painful and hard  on an unspecified date with outcome of unknown , she stated to move her hair even to the touch it is painful  on an unspecified date with outcome of unknown , definitely something abnormal  on an unspecified date with outcome of unknown , her hands, mainly her right, and ankles are swollen  on an unspecified date with outcome of unknown , congested in her chest  on an unspecified date with outcome of unknown , she is feeling a little confused  on an unspecified date with outcome of unknown , chills  on 12Apr2021 with outcome of recovered , fever  on an unspecified date with outcome of unknown , felt achy  on 12Apr2021 with outcome of not recovered , excruciating pain in my head  on 13Apr2021 with outcome of not recovered , swelling of my arms and hands  on 12Apr2021 with outcome of recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient presents with a potential reaction to the COVID19 vaccine. I was summoned to the patient's car by staff. The patient was a passenger in her car. She was found to be responsive but slumped, and lethargic. She is both demented and also non-English speaking. The daughter functioned as a historian and interpreter. She reported the patient was not feeling well on the way to the vaccine and that the drive from home was long. Just prior to the vaccine, the patient had emesis in the vehicle. The vaccine was given. The patient entered the monitoring area and started to report chest tightness. Unfortunately, she was not able to give much more of history at the time of the interview. EMS was summoned and the vehicle was moved to the monitoring area adjacent to the EMS post. The daughter reported that the patient has had a "small heart attack" within the past few months, for which she was hospitalized.
This spontaneous report derives from an internet website where a currently approximately 20-year-old patient of unknown gender reported on themself. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL (dose, route and lot number were unknown). Soon after the vaccination, the patient faced with the extreme fatigue and was slacking in school. The patient was in the swim team but was unable to participate or go to practices. They would come home from school, fall asleep at 15 o'clock and would sleep through the next day. The patient would feel sick and unable to get up. The patient was taken to the diagnostic center where a diagnosis of dysautonomia was made, and then was sent to the neurologist for help with their frequent migraines. There was no preventative medication for the migraines and the only thing they could do was take TYLENOL with codeine and go asleep. Sleep helped take away the migraine. The patient did not recover from the adverse events ("still tired a lot and get migraines"), but they learned to deal with them. The reporter did not assess the relationship between the suspect drug and the events (the patient's doctors rejected the idea that the vaccine was associated with the events, they blamed it on dysautonomia and said that tiredness could be due to the fact that the patient was playing all of the sports and then suddenly stopped). This is one of several reports received from the same source. Additional information has been requested.
Simply that I felt very very tired/weak 2nd day after injection. Didn't go to work that day. No other symptoms. Felt fine with no side effects on the 3rd day or any other
I have not had an adverse reaction, I don?t know if I clicked something accidentally on my v-safe but I was taken aback at the call I received and didn?t want you thinking I was suffering from a reaction. I did go to the doctor for a sore throat this week, and I think I wrote something to indicate that on my v-safe, but I was Covid negative and don?t think it was connected. The previous v-safe I filled out in May I actively had COVID-19 so I?m rather perplexed at being contacted about this one.  Also, I only chose 11/3/22 because I had to pick a date to proceed, I was not having a reaction then.
Had hives at site of vaccination, bilateral legs and on buttocks, under chin, bilateral upper extremities.
Severe headache, dizziness. Fever, nausea and localized swelling. Pain at injection site that kept her awake and precluded any activity for 5 days.
I was having hot flashes and cold chills at the sametime.  I couldn't regulate my body temperature.  Bodyaches and sneezing.  This last about 3 days.  I also had extreme fatigue, which lasted around 2 weeks.
This spontaneous report was received from a female patient of unknown age with increased cholesterol, allergy to cephalosporin antibiotics and with no pertinent medical history who was reporting on herself. On 15-OCT-2017 (reported as "this past Sunday"), the patient was vaccinated with a dose of ZOSTAVAX injection, in the right arm, (dose, dose number, route of administration, lot number and expiration date were not provided) to prevent shingles. Concomitant therapies included unspecified statin drug to lower cholesterol and PREVACID. The patient stated that she got headache the day she got the vaccine (on 15-OCT-2017). She also reported that she developed redness at the injection site which had grown to about 4 inches in diameter on an unknown date in October 2017. It was also reported that the redness site seemed hot (on an unknown date in October 2017). The patient's laboratory diagnostic studies included blood work for cholesterol and for thyroids levels. The patient did not seek medical attention. The outcome of headache, injection site warmth and injection site erythema was unknown at the time of the report. The relatedness between the adverse events and ZOSTAVAX was not provided. Additional information is not expected as no consent was given to follow-up.
Patient received his first dose of the Moderna COVID-19 vaccines on 29-JUN-2022. He never received a second dose of the vaccine.; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Patient received his first dose of the Moderna COVID-19 vaccines on 29-JUN-2022. He never received a second dose of the vaccine.) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Jun-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Patient received his first dose of the Moderna COVID-19 vaccines on 29-JUN-2022. He never received a second dose of the vaccine.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Patient received his first dose of the Moderna COVID-19 vaccines on 29-JUN-2022. He never received a second dose of the vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (Patient received his first dose of the Moderna COVID-19 vaccines on 29-JUN-2022. He never received a second dose of the vaccine.).    No concomitant medications was reported. No treatment drug details was reported.   Reporter did not allow further contact
Patient reported that she received the 1st dose of COVID-19 Pfizer vaccination on July 30, 2021, Lot #FA7484.  She reported that she became very sick approximately one week later and was diagnosed with COVID.  She was bed-ridden for 5 to 6 days, had a low-grade fever, chills and fatigue.  Patient realized she was pregnant in November 2021 and had a miscarriage shortly thereafter on 11/24/2021.
no side effects reported; administration of an expired VAQTA vaccine; This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's concurrent condition, concomitant medication and historical condition were not provided.  On 15-OCT-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # S024396, expiration date reported as 12-OCT-2020 (strengh, dose, route of administration and anatomical location of vaccine were not reported) for prophylaxis. No side effects were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S024396; expirationdate: 12-OCT-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Itchy hives all over body; Itchy hives all over body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BAYER ASPIRIN), HYDROCHLOROTHIAZIDE and MELOXICAM for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication including vitamins was reported.
Mother reported, around 3 hours after injection - c/o fatigue, had fever (tactile est. 101 degrees) and sore throat. She slept 18 hours overnight into the day after injection. Within 24 hours of HBV, symptoms resolved. Only treatment was ASA 325 mg given by mother. (this was not advised by us)
L lateral thigh and size: 6in x 6in. Color: red. Infectious signs: no drainage, fluctuance, or lymphangitic streaking and warmth, erythema, and induration.  proquad given subQ and superior location and quadracel inferior location. blanching and warm, mildly tender, but otherwise well. continue benadryl, tylenol. can add topical steroid cream BID. start cephalexin if enlarging size or streaking. will report to VAERS. hydrocortisone 2.5 % topical ointment - apply twice daily for 7 days     Qty: (1)  30 gram tube  cephalexin 250 mg/5 mL oral suspension - Take 5 mL twice a day by oral route for 7 days.
On May 24, 1999 the pt experienced varicella with approximately 50 lesions on the chest, back, thigh and neck.
Temperature excursions during a period of 33 weeks on 2021/Each time vial was put into cooler, sometimes there was a period 1 hr or 1.5hr approximately, when temperature data logger registered 34 or 35°F; Dose administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/Each time vial was put into cooler, sometimes there was a period 1 hr or 1.5hr approximately, when temperature data logger registered 34 or 35°F) and POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 1:18 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 12:09 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/Each time vial was put into cooler, sometimes there was a period 1 hr or 1.5hr approximately, when temperature data logger registered 34 or 35°F) and POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/Each time vial was put into cooler, sometimes there was a period 1 hr or 1.5hr approximately, when temperature data logger registered 34 or 35°F) and POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was given as 64.27. No concomitant medications were reported. The vial was initially moved to the fridge on 09-Mar-2021 and proposed beyond use date was 08-Apr-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. On the date of administration, at 09:00 A.M., the temperature recorded was 34 degree Fahrenheit and at 10:00 A.M., the temperature recorded was 30 degree Fahrenheit that has been reached by the vial. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Patient fainted after receiving the vaccine. He stated that this happens when he receives vaccines. He had not eaten this morning. He experienced very mild (less than 5 seconds in duration) shaking and clinching of left hand.
Information has been received from a registered nurse referring to multiple unspecified patients (age and gender unknown). The patients' concurrent conditions, medical history and concomitant therapies were not reported. On unknown dates, the patients were administered improperly stored doses of VARIVAX (lot # L049536 with expiration date of 12-AUG-2017, lot # M009764 with expiration date of 23-FEB-2018, lot # L044524 with expiration date of 09-NOV-2017, lot # M025867 with expiration date of 24-MAY-2018, lot # M017291 with expiration date of 07-APR-2018, dose and route unknown). The vaccines were exposed to 10.9 Fahrenheit (F) for 24 hours, 14.7 F for 24 hours, 6.1 F for 72 hours, 6.0 F for 120 hours, 8.1 F for 48 hours, 6.1 F for 24 hours, 10.9 F for 192 hours, 10.2 F for 48 hours, 11.8 F for 192 hours, and 9.1 F for 48 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient stated that she developed a high temperature the evening following the administration of the vaccine. The temperature ranged from 103.4 the first night followed by 101.6 and 100.3 the following consecutive nights
Injection site swelling and pain, muscle aches, fever, chills, sweats, congestion, runny nose, headache
Patient came to the pharmacy on 9/26/21 complaining of complications due to his second Moderna COVID-19 vaccine, which he received on 6/16/21. The patient stated that the administrating pharmacist "jabbed and possibly twisted" the needle into his left bicep instead of the deltoid. He said it was very painful and caused so much bleeding that the pharmacist had to get more band aids from the back of the pharmacy. He also said that it was still bleeding when he got home from the pharmacy. Since getting his second dose, he claims that his left arm has been very weak to the point where he has dropped grocery bags he was carrying. He also developed a small/hard bump on his left wrist that he noticed on 9/25/21. He stated that nothing else in his life has changed so he is attributing these complications to an error in administering the second dose. He has not seen a doctor regarding these issues and his PQCF from 6/16/21 says that he does not have PCP. I recommended that he see a doctor and he said he plans on going to a medical clinic at his work tomorrow to get it looked at. He thinks he will need to get a referral to see a specialist because it is affecting his work. The patient also plans to come back tomorrow to speak with the pharmacy manager. He wants the incident documented; I told him that I planned on submitting an SCRT report to Walmart and a report through the CDC's VAERS. I also contacted our PCSM.
Within 1-2 hrs heavy breathing, increased fever, swollen lymph nodes, limp.  To Urgent care sat. A.M. (4/17/10) continues. to have fever spikes 4/20/10.
Noticed both after 1st and 2nd dose, within 1st 4-5 days. Flu-like symptoms. Sleeplessness, fever (100.0), nausea, vomiting, myalgia, arthralgia, diarrhea. No treatment.